More Lymphoma (Hodgkin's & Non) News

• Mozobil Boosts Stem Cells Before Bone Marrow Transplants

  December 19 (HealthDay News) -- The Genzyme Corp. drug Mozobil (plerixafor) has been approved by ...

• Statin Use Doesn't Inhibit Lymphoma Drug Therapy

  December 9 (HealthDay News) -- Cholesterol-lowering statin drugs don't interfere with rituximab, a medication used ...

• Genes May Predict Lymphoma Treatment Outcome

  November 26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a ...

• Silicone Breast Implants Might Raise Risk of Rare Lymphoma

  November 4 (HealthDay News) -- Women with silicone breast implants may have a higher risk ...

• Poverty Raises Mortality Risk with Non-Hodgkin Lymphoma

  October 20 (HealthDay News) -- The risk of death for someone with non-Hodgkin lymphoma increases ...

• Ontak Approved to Treat T-Cell Lymphoma

  October. 17 (HealthDay News) -- The Eisai Corp. drug Ontak (denileukin diftitox) has been approved ...

• Survival Rates Improve for Kids with Blood Cancers

  September 10 (HealthDay News) -- In the United States, 5- and 10-year survival rates continue ...

• New Lymphoma Drug Shows Promise

  August 14 (HealthDay News) -- Preliminary results from an early trial of a new immunotherapy ...

• Incidence of Mantle Cell Lymphoma on Rise

  July 18 (HealthDay News) -- The prevalence of mantle cell lymphoma, an aggressive form ...

• Research Uncovers Clues to Lymphoma

  June 24 (HealthDay News) U.S. researchers say they've spotted an important factor in the development ...

• Young Hodgkin Survivors Face Later Risk of Second Cancers

  June 1 (HealthDay News) -- People who survived Hodgkin disease when they were children or ...

• Hodgkin Lymphoma Kids Face Greater Risk of Future Problems

  May 31 (HealthDay News) -- People who survived Hodgkin lymphoma as children have an increased ...

• Fighting Cancer with a Pen

  March 14 (HealthDay News) -- When 69-year-old Carl Irwin arrived at Georgetown University's Lombardi Comprehensive ...

• Radioimmunotherapy After Chemo Safe for Common Lymphoma

  March 14 (HealthDay News) -- Radioimmunotherapy after chemotherapy is safe and effective for patients with ...

• Outcomes Improve for Non-Hodgkin Lymphoma Patients

  March 11 (HealthDay News) -- Between 1990 and 2004, five- and 10-year survival rates for ...

• Combo Treatment Best for Elderly Lymphoma Patients

  Jan. 16 (HealthDay News) -- Treatment that combines the monoclonal antibody rituximab with six cycles ...

• Malaria Drug Promising Against Cancer

  Dec. 27 (HealthDay News) -- A common anti-malaria drug called chloroquine can also prevent the ...

• Possible Cure for Rare Lymphoma Reported

  Dec. 10 (HealthDay News) -- Danish researchers are reporting what appears to be a cure ...

• Doctors Report High Survival Rates for Hodgkin's Disease

  Nov. 8 (HealthDay News) -- Here's an example of progress in cancer treatment: a trial ...